Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Smith

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled TrialKeerthi Anpalagan, Ravindra Dotel, Derek R MacFadden, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancerMinsuk Kwon, Gahyun Kim, Ryul Kim, et al.
BMJ Open Respiratory Research|October 11, 2020
Classification of aerosol-generating procedures: a rapid systematic reviewTanya Jackson, Danika Deibert, Graeme Wyatt, et al.
Annals of Surgical Oncology|July 11, 2018
Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome CorrelationsBarbara Schwartzberg, John Lewin, Osama Abdelatif, et al.
Annals of Surgical Oncology|October 10, 2018
Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome CorrelationsBarbara Schwartzberg, John Lewin, Osama Abdelatif, et al.
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
Molecular Biology and Evolution|February 16, 2022
Phylodynamic Inference of Bacterial Outbreak Parameters Using Nanopore SequencingEike Steinig, Sebastián Duchêne, Izzard Aglua, et al.
Journal for Immunotherapy of Cancer|March 22, 2022
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockadeEmmanuel C Patin, Magnus T Dillon, Pablo Nenclares, et al.
Chirurgia (Bucharest, Romania : 1990)|September 3, 2020
The Challenge of COVID-19: The Biological Characteristics and Outcomes in a Series of 130 Breast Cancer Patients Operated on During the PandemicAbdalla Saad Abdalla, Amira Asaad, Rebecca Fisher, et al.
Emerging Infectious Diseases|October 25, 2023
Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, AustraliaSimon Smith, Tonia Marquardt, Amy V Jennison, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
Does Adjunctive Clindamycin Have a Role in Staphylococcus aureus Bacteremia? A Protocol for the Adjunctive Treatment Domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) Randomized Controlled TrialKeerthi Anpalagan, Ravindra Dotel, Derek R MacFadden, et al.
Journal for Immunotherapy of Cancer|July 5, 2022
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancerMinsuk Kwon, Gahyun Kim, Ryul Kim, et al.
BMJ Open Respiratory Research|October 11, 2020
Classification of aerosol-generating procedures: a rapid systematic reviewTanya Jackson, Danika Deibert, Graeme Wyatt, et al.
Annals of Surgical Oncology|July 11, 2018
Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome CorrelationsBarbara Schwartzberg, John Lewin, Osama Abdelatif, et al.
Annals of Surgical Oncology|October 10, 2018
Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome CorrelationsBarbara Schwartzberg, John Lewin, Osama Abdelatif, et al.
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
Molecular Biology and Evolution|February 16, 2022
Phylodynamic Inference of Bacterial Outbreak Parameters Using Nanopore SequencingEike Steinig, Sebastián Duchêne, Izzard Aglua, et al.
Journal for Immunotherapy of Cancer|March 22, 2022
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockadeEmmanuel C Patin, Magnus T Dillon, Pablo Nenclares, et al.
Chirurgia (Bucharest, Romania : 1990)|September 3, 2020
The Challenge of COVID-19: The Biological Characteristics and Outcomes in a Series of 130 Breast Cancer Patients Operated on During the PandemicAbdalla Saad Abdalla, Amira Asaad, Rebecca Fisher, et al.
Emerging Infectious Diseases|October 25, 2023
Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, AustraliaSimon Smith, Tonia Marquardt, Amy V Jennison, et al.
Pageof 22